Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Risperidone (Primary)
- Indications Psychotic disorders; Schizophrenia
- Focus Therapeutic Use
- 14 Dec 2007 New trial record.